Literature DB >> 28528688

Human papillomavirus molecular biology.

Mallory E Harden1, Karl Munger2.   

Abstract

Human papillomaviruses are small DNA viruses with a tropism for squamous epithelia. A unique aspect of human papillomavirus molecular biology involves dependence on the differentiation status of the host epithelial cell to complete the viral lifecycle. A small group of these viruses are the etiologic agents of several types of human cancers, including oral and anogenital tract carcinomas. This review focuses on the basic molecular biology of human papillomaviruses.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Epithelial differentiation; Human papillomavirus; Oncogene; Tumor suppressor; Vaccine

Mesh：

Substances：

Year:  2016        PMID： 28528688      PMCID： PMC5500221          DOI： 10.1016/j.mrrev.2016.07.002

Source DB:  PubMed          Journal:  Mutat Res Rev Mutat Res        ISSN： 1383-5742            Impact factor:   5.657


  131 in total

1.  Nuclear import of HPV11 L1 capsid protein is mediated by karyopherin alpha2beta1 heterodimers.

Authors:  E Merle; R C Rose; L LeRoux; J Moroianu
Journal:  J Cell Biochem       Date:  1999-09-15       Impact factor: 4.429

2.  Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Authors:  Rebecca M Richards; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 3.  The human papillomavirus E7 protein shines a spotlight on the pRB family member, p130.

Authors:  Ann Roman
Journal:  Cell Cycle       Date:  2006-03-15       Impact factor: 4.534

4.  Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.

Authors:  Mark H Stoler; R Marshall Austin; Chengquan Zhao
Journal:  J Clin Microbiol       Date:  2015-05-06       Impact factor: 5.948

5.  A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Authors:  Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

6.  Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Authors:  Nubia Muñoz; Susanne K Kjaer; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricía J Garcia; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Marc Steben; F Xavier Bosch; Joakim Dillner; Warner K Huh; Elmar A Joura; Robert J Kurman; Slawomir Majewski; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine T Bryan; Lisa C Lupinacci; Katherine E D Giacoletti; Heather L Sings; Margaret K James; Teresa M Hesley; Eliav Barr; Richard M Haupt
Journal:  J Natl Cancer Inst       Date:  2010-02-05       Impact factor: 13.506

Review 7.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

8.  Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.

Authors:  Hammad Ali; Basil Donovan; Handan Wand; Tim R H Read; David G Regan; Andrew E Grulich; Christopher K Fairley; Rebecca J Guy
Journal:  BMJ       Date:  2013-04-18

Review 9.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

10.  Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England.

Authors:  D Mesher; K Soldan; R Howell-Jones; K Panwar; P Manyenga; M Jit; S Beddows; O N Gill
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641
View more
  42 in total

Review 1.  More than just oncogenes: mechanisms of tumorigenesis by human viruses.

Authors:  Marta M Gaglia; Karl Munger
Journal:  Curr Opin Virol       Date:  2018-09-27       Impact factor: 7.090

2.  Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors.

Authors:  M Schneider; M Müller; A Yigitliler; J Xi; C Simon; T Feger; H-J Rziha; F Stubenrauch; H-G Rammensee; T Iftner; R Amann
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

3.  Prevalence and genotype distribution of human papillomavirus infection among women aged 30-65 years in Xi'an, China: a population-based study of 14,655 women.

Authors:  Xiaoxiao Han; Guozhong Song; Yufang Li; Zhaoqiang Dong; Xianchun Yan; Suqing Wang; Huizhen Tian; Xiaohong Wu; Chen Li; Yi Huo
Journal:  Hum Vaccin Immunother       Date:  2021-12-10       Impact factor: 3.452

Review 4.  Biology of HPV Mediated Carcinogenesis and Tumor Progression.

Authors:  Pippa F Cosper; Samantha Bradley; Lexi Luo; Randall J Kimple
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

5.  High prevalence of sexual infection by human papillomavirus and Chlamydia trachomatis in sexually-active women from a large city in the Amazon region of Brazil.

Authors:  Leonardo Miranda Dos Santos; Josiellem Damasceno de Souza; Hilary Acha Mbakwa; Akim Felipe Santos Nobre; Rodrigo Covre Vieira; Stephen Francis Ferrari; Anderson Raiol Rodrigues; Edna Aoba Yassui Ishikawa; João Farias Guerreiro; Maísa Silva de Sousa
Journal:  PLoS One       Date:  2022-07-18       Impact factor: 3.752

6.  Structural and biochemical analysis of the PTPN4 PDZ domain bound to the C-terminal tail of the human papillomavirus E6 oncoprotein.

Authors:  Hye Seon Lee; Hye-Yeoung Yun; Eun-Woo Lee; Ho-Chul Shin; Seung Jun Kim; Bonsu Ku
Journal:  J Microbiol       Date:  2022-01-28       Impact factor: 2.902

7.  A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.

Authors:  Felix A Ebner; Carolin Sailer; Daniela Eichbichler; Jasmin Jansen; Anna Sladewska-Marquardt; Florian Stengel; Martin Scheffner
Journal:  J Biol Chem       Date:  2020-08-27       Impact factor: 5.157

8.  Occupational exposure of oropharyngeal human papillomavirus amongst otolaryngologists.

Authors:  Rahul S Subbarayan; Matthew Shew; Jonathan Enders; Andrés M Bur; Sufi M Thomas
Journal:  Laryngoscope       Date:  2019-11-11       Impact factor: 3.325

Review 9.  Structural Insights in Multifunctional Papillomavirus Oncoproteins.

Authors:  Irina Suarez; Gilles Trave
Journal:  Viruses       Date:  2018-01-15       Impact factor: 5.048

10.  Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin-specific peptidase 9, X-linked in oral squamous cell carcinoma.

Authors:  Wu Jingjing; Guo Wenzheng; Wen Donghua; Hou Guangyu; Zhou Aiping; Wu Wenjuan
Journal:  Cancer Med       Date:  2018-07-10       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.